Abu Dhabi, UAE: ART Fertility Clinics, a global leader in reproductive medicine, has successfully helped an Emirati couple welcome their first child after more than two decadesof primary infertility. This outcome, resulting from the clinic’s advanced diagnostic capabilities and precision treatment protocols, resolves a complex case through comprehensive genetic analysis and personalized assisted reproductive technology.
The Clinical Challenge: Decades of Unexplained Infertility
As per the World Health Organization (WHO), infertility affects one in six people worldwide. In the GCC region, infertility prevalence is estimated to be around 15% or higher, with similar rates reported in the UAE.
After steering through the emotional and physical toll of infertility for over two decades and numerous failed IVF attempts in the UAE and across the Gulf, Europe, Asia, and the United States, the diagnosis this couple received repeatedly was “unexplained infertility.”
This classification, which affects approximately 10-30% of infertile couples, often leads to empirical treatment cycles with diminished success probabilities.
Advances in reproductive medicine now recognize thatgenetic and chromosomal factors are key to understandingrecurrent implantation failure, with comprehensive testing capable of identifying a root cause in up to half of these cases. For this patient, identifying such factors was even more critical, as the challenge was compounded by her advanced maternal age, a demographic where IVF success rates typically decline to 20% or less per cycle for women aged over 40.
The Diagnostic Pivot: Uncovering the Root Cause
Diverging from standard assessment protocols, ART Fertility Clinics initiated comprehensive genetic testing within the first month of patient consultation, an evaluation that had not been performed during the couple’s extensive treatment history overseas. This advanced genetic analysis rapidly identified a specific chromosomal abnormality that had remained undetected throughout more than two decades of unsuccessful treatment attempts.
Armed with this definitive diagnosis, the medical team at ART Fertility Clinics designed a personalized assisted reproductive treatment plan that addressed the couple’s unique situation. The patient underwent multiple IVF/ICSI treatment cycles with Preimplantation Genetic Testing for Aneuploidy (PGT-A) to identify chromosomally normal, good-quality embryos suitable for transfer. A carefully timed and personalized frozen embryo transfer cycle with prepared uterine lining was then performed to maximize implantation chances. This meticulously planned approach resulted in successful pregnancy and the birth of a healthy baby boy after 26 long years of wait.
Contextualizing the Achievement Within the GCC Healthcare Landscape:
This successful outcome highlights the UAE’s ascendance as a premier destination for medical tourism. The UAE medical tourism market was valued at approximately USD 629 million in 2023 and is estimated to reach USD 2.3 billion by 2033.
ART Fertility Clinics is a cornerstone of this ecosystem, offering a technological and diagnostic portfolio on par with leading international centers. The clinic’s integrated service model, which includes an in-house state-of-the-art genetics lab (“ART Genomics”), provides precise diagnostic foundation for personalized fertility treatment.
ART Fertility Clinics’ Commitment to Advancing Reproductive Medicine:
For patients with a history of repeated IVF failure, the emotional and financial cost of empirical treatment can be immense, often extending the journey to parenthood by several years. ART Fertility Clinics encourages couples facing complex infertility challenges, including those with unexplained infertility, advanced maternal age, or repeated IVF failures, to seek a comprehensive diagnostic evaluation. The clinic’s expertise in advanced genetic diagnostics and personalized treatment protocols offers a viable pathway to success for cases previously considered intractable.
About ART Fertility Clinics:
Since establishing its flagship centre in Abu Dhabi in 2015, ART Fertility Clinics has become the leading IVF clinics in the Middle East. The brand has expanded its presence in the GCC, with clinics in Abu Dhabi, Al Ain, and Dubai. Since its inception, ART Fertility Clinics has been led by Mr. Suresh Soni, Chief Executive Officer, and Prof. Dr. Human Fatemi, Group Medical Director.
For nearly a decade, the clinics have consistently offered patients top-tier expertise, care, and empathy, establishing them as one of the market leaders throughout the Middle East.
